# Healthequity (HQY) — Earnings

HQY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/hqy/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2027 |
| Period end | Jul 31, 2026 |
| EPS actual | $1.24 |
| EPS estimate | $1.19 |
| EPS surprise | +3.92% |
| Revenue surprise | +0.42% |
| Revenue | $350.7M |
| Revenue estimate | $349.2M |
| Reported | Aug 27, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1428336/000142833626000041/hqy-20260731.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/fe0168ac-1849-9f2d-b56f-0e572d66479f.html) |

HealthEquity reported fiscal Q2 2027 results on August 27, 2026, for the quarter ended July 31, 2026. Earnings per share were $1.24, beating the $1.19 estimate by 3.92%. Revenue was $350.7 million, just above the $349.2 million consensus. Compared with fiscal Q2 2026, EPS rose about 15% from $1.08 and revenue rose about 7.6% from $325.8 million.

Earnings have climbed steadily. Annual EPS went from $1.35 in fiscal 2023 to $2.26 in fiscal 2024, $3.13 in fiscal 2025 and $4.01 in fiscal 2026, nearly three times the fiscal 2023 level. The first half of fiscal 2027 totals $2.48 per share, about 21% more than the $2.05 a year earlier. Fiscal Q1 and Q2 2027 share the EPS high in the table at $1.24, and fiscal Q1 2027 set the revenue high at $354.6 million. HealthEquity beat EPS estimates in 17 of the last 20 quarters, including each of the last six.

Fiscal Q3 results were reported between December 3 and December 9 in each of the past four years. That points to early December 2026 for the next report, which will show whether the year-over-year EPS growth seen this year carries into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2027 | Aug 27, 2026 | $1.19 | $1.24 | 3.92% | $349.2M | $350.7M |
| Q1 2027 | May 28, 2026 | $1.11 | $1.24 | 11.23% | $352.0M | $354.6M |
| Q4 2026 | Mar 17, 2026 | $0.90 | $0.95 | 5.83% | $332.3M | $334.6M |
| Q3 2026 | Dec 3, 2025 | $0.91 | $1.01 | 10.71% | $320.6M | $322.2M |
| Q2 2026 | Sep 2, 2025 | $0.91 | $1.08 | 18.14% | $320.7M | $325.8M |
| Q1 2026 | Jun 3, 2025 | $0.81 | $0.97 | 19.34% | $322.3M | $330.8M |
| Q4 2025 | Mar 18, 2025 | $0.72 | $0.69 | -3.63% | $305.8M | $311.8M |
| Q3 2025 | Dec 9, 2024 | $0.72 | $0.78 | 7.99% | $290.1M | $300.4M |
| Q2 2025 | Sep 3, 2024 | $0.70 | $0.86 | 23.03% | $285.1M | $299.9M |
| Q1 2025 | Jun 3, 2024 | $0.66 | $0.80 | 21.88% | $277.9M | $287.6M |
| Q4 2024 | Mar 19, 2024 | $0.57 | $0.63 | 10.94% | $258.7M | $262.4M |
| Q3 2024 | Dec 5, 2023 | $0.50 | $0.60 | 20.02% | $243.6M | $249.2M |
| Q2 2024 | Sep 5, 2023 | $0.48 | $0.53 | 11.11% | $240.0M | $243.5M |
| Q1 2024 | Jun 5, 2023 | $0.41 | $0.50 | 23.37% | $239.4M | $244.4M |
| Q4 2023 | Mar 21, 2023 | $0.35 | $0.37 | 5.96% | $230.7M | $233.8M |
| Q3 2023 | Dec 6, 2022 | $0.35 | $0.38 | 9.64% | $206.8M | $216.1M |
| Q2 2023 | Sep 6, 2022 | $0.33 | $0.33 | -0.06% | $203.9M | $206.1M |
| Q1 2023 | Jun 6, 2022 | $0.26 | $0.27 | 3.85% | $204.0M | $205.7M |
| Q4 2022 | Mar 22, 2022 | $0.21 | $0.20 | -6.80% | $199.9M | $203.3M |
| Q3 2022 | Dec 6, 2021 | $0.35 | $0.35 | 0.92% | $184.0M | $180.0M |

## Frequently Asked Questions

### When did Healthequity (HQY) last report earnings?

Healthequity last reported on Aug 27, 2026, covering fiscal Q2 2027.

### Did HQY beat earnings estimates?

Yes. Healthequity reported EPS of $1.24 for Q2 2027 against a $1.19 estimate — a 3.92% beat.

### How much revenue did HQY report last quarter?

Healthequity reported $350.7M in revenue for Q2 2027, against a consensus estimate of $349.2M.

## Similar Stocks

- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).